Cell culturing is a process through which cells are grown away from their natural environment in controlled laboratory conditions. Cell cultures help in carcinogenesis and mutagenesis studies and for studying the biochemistry and physiology of cells, the effect of biomolecules and drugs on cells, and is used in cellular and molecular biology. Cell culture provides reproducibility and consistency of results that is achieved by the usage of a batch of clonal cells. Research into various diseases such as Alzheimer’s, Parkinson’s, and diabetes uses cell culture to study cellular mechanisms.
The global cell culture market is expected to reach a value of US$11.3 billion by 2022, growing at a CAGR of 7.1% from 2014. Globally, the cell culture market is experiencing tremendous growth due to the demand for biopharmaceutical products. The cell culture market is expanding due to the amplified biologic drugs market and related uses in vaccines, proteins, and antibodies. Stem cell therapy is used for treating a variety of diseases and increase in stem cell research is directly boosting the cell culture market.
Request a Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=405
Advent of New Research Technologies and Increased Investment Boost Cell Culture Market
Government initiatives for improvement of healthcare infrastructure and investment in research are the prime reasons for the augmentation of the global cell culture market. Private and public investment in biological products is also a major factor responsible for boosting the cell culture market. The global cell culture market is expanding and providing great market opportunities due to progression in cell culture technologies such as 3D cell culturing by magnetic levitation, nano-particle facilitated magnetic levitation, and recombinant DNA.
Cell cultures are used for biological manufacturing, cancer research, gene therapy, stem cell research, IVF technology, diagnosing diseases, and for drug screening and monitoring. Investments by life science organizations and collaborations between industries and academic centers are propelling the global cell culture market.
Cell Culture Media Expected to Grow Fastest
The segmentation of the cell culture market by product type breaks down the market into two categories: instruments and consumables, which are sub-segmented into reagents, media and sera. Cell culture media are the most rapidly growing segment owing to them being animal-derived component free (ADCF). The instruments segment is broken down into the sub-segments of cryostorage equipment, roller bottle equipment, incubators, pipetting instruments, and culture systems. Technological innovations and demand for automated culture is driving the demand for this segment.
In North America, large-scale drug development and the presence of major companies dealing in biotechnology, pharmaceuticals, and food and beverages made the region the largest regional cell culture market in 2013; Europe follows North America in the market hierarchy. Asia Pacific is anticipated to grow rapidly as a regional cell culture market due to economic improvement in countries such as India, China, Japan, and Australia. Rest of the World (RoW) and Latin America are also expected to grow substantially owing to augmented investment by private and public institutions in life science research.
Key players in the global cell culture market include BD Biosciences, EMD Millipore, Thermo Fisher Scientific, Corning Incorporated, Sigma-Aldrich Corporation, Inc., GE Healthcare, VWR International, PromoCell GmbH, and. Lonza Biosciences.
Browse Full Global Cell Culture Market Report With Complete TOC @ http://www.transparencymarketresearch.com/cell-culture-market.html
The global cell culture market is expected to reach a value of US$11.3 billion by 2022, growing at a CAGR of 7.1% from 2014. Globally, the cell culture market is experiencing tremendous growth due to the demand for biopharmaceutical products. The cell culture market is expanding due to the amplified biologic drugs market and related uses in vaccines, proteins, and antibodies. Stem cell therapy is used for treating a variety of diseases and increase in stem cell research is directly boosting the cell culture market.
Request a Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=405
Advent of New Research Technologies and Increased Investment Boost Cell Culture Market
Government initiatives for improvement of healthcare infrastructure and investment in research are the prime reasons for the augmentation of the global cell culture market. Private and public investment in biological products is also a major factor responsible for boosting the cell culture market. The global cell culture market is expanding and providing great market opportunities due to progression in cell culture technologies such as 3D cell culturing by magnetic levitation, nano-particle facilitated magnetic levitation, and recombinant DNA.
Cell cultures are used for biological manufacturing, cancer research, gene therapy, stem cell research, IVF technology, diagnosing diseases, and for drug screening and monitoring. Investments by life science organizations and collaborations between industries and academic centers are propelling the global cell culture market.
Cell Culture Media Expected to Grow Fastest
The segmentation of the cell culture market by product type breaks down the market into two categories: instruments and consumables, which are sub-segmented into reagents, media and sera. Cell culture media are the most rapidly growing segment owing to them being animal-derived component free (ADCF). The instruments segment is broken down into the sub-segments of cryostorage equipment, roller bottle equipment, incubators, pipetting instruments, and culture systems. Technological innovations and demand for automated culture is driving the demand for this segment.
In North America, large-scale drug development and the presence of major companies dealing in biotechnology, pharmaceuticals, and food and beverages made the region the largest regional cell culture market in 2013; Europe follows North America in the market hierarchy. Asia Pacific is anticipated to grow rapidly as a regional cell culture market due to economic improvement in countries such as India, China, Japan, and Australia. Rest of the World (RoW) and Latin America are also expected to grow substantially owing to augmented investment by private and public institutions in life science research.
Key players in the global cell culture market include BD Biosciences, EMD Millipore, Thermo Fisher Scientific, Corning Incorporated, Sigma-Aldrich Corporation, Inc., GE Healthcare, VWR International, PromoCell GmbH, and. Lonza Biosciences.
Browse Full Global Cell Culture Market Report With Complete TOC @ http://www.transparencymarketresearch.com/cell-culture-market.html
No comments:
Post a Comment
Did you like blog? Share your thoughts -